NCT00541697
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,045 public trials
714 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00110435
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +8 more
- Locations
-
Not specified
NCT00480805
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
Not specified
NCT06552923
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- CommuniCare Davis Family Health Center Davis, California, United States
- St Agnes Medical Center Fresno, California, United States
- La Clinica Multiple Locations, California, United States
- Santa Rosa Community Health Centers Multiple Locations, California, United States
NCT06548997
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
- Locations
-
- Gan & Lee Pharmaceuticals Co., Ltd Beijing, China
NCT03534687
- Conditions
- Alzheimer Disease 10, Behavior, Diabetes Mellitus, +6 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
NCT01165190
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Clinical Research Unit Tempe, Arizona, United States
- Tempe, Arizona, United States
Completed
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Qps-Mra, Llc South Miami, Florida, United States
NCT01667783
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
Completed
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
- Locations
-
- Texas Diabetes Institute San Antonio, Texas, United States